Authors:
Nikitina, EY
Clark, JI
van Beynen, J
Chada, S
Virmani, AK
Carbone, DP
Gabrilovich, DI
Citation: Ey. Nikitina et al., Dendritic cells transduced with full-length wild-type p53 generate antitumor cytotoxic T lymphocytes from peripheral blood of cancer patients, CLIN CANC R, 7(1), 2001, pp. 127-135
Authors:
Young, MRI
Petruzelli, GJ
Kolesiak, K
Achille, N
Lathers, DMR
Gabrilovich, DI
Citation: Mri. Young et al., Human squamous cell carcinomas of the head and neck chemoattract immune suppressive CD34(+) progenitor cells, HUMAN IMMUN, 62(4), 2001, pp. 332-341
Authors:
Lisziewicz, J
Gabrilovich, DI
Varga, G
Xu, JQ
Greenberg, PD
Arya, SK
Bosch, M
Behr, JP
Lori, F
Citation: J. Lisziewicz et al., Induction of potent human immunodeficiency virus type 1-specific T-cell-restricted immunity by genetically modified dendritic cells, J VIROLOGY, 75(16), 2001, pp. 7621-7628
Authors:
Gabrilovich, DI
Velders, MP
Sotomayor, EM
Kast, WM
Citation: Di. Gabrilovich et al., Mechanism of immune dysfunction in cancer mediated by immature Gr-1(+) myeloid cells, J IMMUNOL, 166(9), 2001, pp. 5398-5406
Authors:
Almand, B
Clark, JI
Nikitina, E
van Beynen, J
English, NR
Knight, SC
Carbone, DP
Gabrilovich, DI
Citation: B. Almand et al., Increased production of immature myeloid cells in cancer patients: A mechanism of immunosuppression in cancer, J IMMUNOL, 166(1), 2001, pp. 678-689
Citation: Ey. Nikitina et Di. Gabrilovich, Combination of gamma-irradiation and dendritic cell administration inducesa potent antitumor response in tumor-bearing mice: Approach to treatment of advanced stage cancer, INT J CANC, 94(6), 2001, pp. 825-833
Authors:
Dikov, MM
Oyama, T
Cheng, PY
Takahashi, T
Takahashi, K
Sepetavec, T
Edwards, B
Adachi, Y
Nadaf, S
Daniel, T
Gabrilovich, DI
Carbone, DP
Citation: Mm. Dikov et al., Vascular endothelial growth factor effects on nuclear factor-kappa B activation in hematopoietic progenitor cells, CANCER RES, 61(5), 2001, pp. 2015-2021
Authors:
Gabrilovich, DI
Ishida, T
Nadaf, S
Ohm, JE
Carbone, DP
Citation: Di. Gabrilovich et al., Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function, CLIN CANC R, 5(10), 1999, pp. 2963-2970
Authors:
Young, MRI
Kolesiak, K
Wright, MA
Gabrilovich, DI
Citation: Mri. Young et al., Chemoattraction of femoral CD34(+) progenitor cells by tumor-derived vascular endothelial cell growth factor, CLIN EXP M, 17(10), 1999, pp. 881-888
Authors:
Ohm, JE
Shurin, MR
Esche, C
Lotze, MT
Carbone, DP
Gabrilovich, DI
Citation: Je. Ohm et al., Effect of vascular endothelial growth factor and FLT3 ligand on dendritic cell generation in vivo, J IMMUNOL, 163(6), 1999, pp. 3260-3268